Pleasant Hill, CA, United States of America

Mark Madden


Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark Madden: Innovator from Pleasant Hill, CA

Introduction:

Mark Madden, a talented inventor hailing from Pleasant Hill, CA, has left a mark in the field of innovations with his remarkable work. With a total of 4 patents under his name, his contributions have significantly impacted the world of technology and biochemistry.

Latest Patents:

Among his latest patents is the groundbreaking invention titled "Metalloprotease having increased activity." This innovative creation involves a novel metalloprotease extracted from a fungus that exhibits enhanced proteolytic capabilities. Additionally, the patent encompasses isolated nucleic acid fragments encoding the metalloprotease, along with vectors, DNA constructs, and recombinant host cells containing these fragments.

Career Highlights:

Mark Madden's professional journey has been enriched by his association with renowned companies such as Novo Nordisk A/S and Novo Nordisk Biotech, Inc. His expertise and dedication have played a pivotal role in driving forward the cutting-edge research and development initiatives undertaken by these esteemed organizations.

Collaborations:

Throughout his career, Mark Madden has collaborated with individuals of exceptional talent, including Sven Branner and Jeffrey R Shuster. Together, they have synergized their skills and knowledge to achieve groundbreaking innovations in the realm of biochemistry and biotechnology.

Conclusion:

In conclusion, Mark Madden stands as a beacon of innovation, showcasing his brilliance through patents that push the boundaries of what is possible. His contributions to the field continue to inspire future inventors and researchers, shaping the landscape of technology and biochemistry for generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…